CIS Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant Insulin) Report

CIS Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs, Recombinant Insulin) Analysis And Segment Forecasts To 2020

Report ID: 978-1-68038-170-2
Number of Pages: 93
Format: Electronic (PDF)

Historical Data: 2011-2013
Industry: Healthcare

Table of Contents

Chapter 1. Executive Summary
1.1. CIS Insulin – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. CIS Insulin Industry Outlook
  2.1. Market Segmentation
  2.2. Market Size and Growth Prospects
  2.3. CIS Insulin Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
  2.4. Key Opportunities Prioritized
  2.5. Industry Analysis - Porter's
  2.6. CIS Insulin - Company Market Share Analysis
  2.7. CIS Insulin Market PESTEL Analysis, 2012
  2.8. CIS Insulin – Pipeline Overview
Chapter 3. CIS Insulin Product Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
  3.1. Rapid Acting Analog
3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
  3.2. Short Acting Insulin
3.2.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
  3.3. Intermediate Acting Insulin
3.3.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
  3.4. Long Acting Analog
3.4.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
  3.5. Pre-Mixed
3.5.1.Pre-Mixed Insulin Market Estimates and Forecasts
3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.5.2.Pre-Mixed Analog Market Estimates and Forecasts
3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
Chapter 4. CIS Insulin Segment (on the basis of source) Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
  4.1. Insulin Analogs
4.1.1.Insulin Analogs Market Estimates and Forecasts
  4.2. Human Recombinant Insulin
4.2.1. Human Recombinant Insulin Market Estimates and Forecasts
Chapter 5. CIS Insulin Application Outlook(USD Million) Estimates and Forecasts, 2012 - 2020
  5.1. Type I and Other Diabetes
5.1.1. Type I and Other Diabetes Market Estimates and Forecasts
  5.2. Type II Diabetes
5.2.1. Type II Diabetes Market Estimates and Forecasts
Chapter 6. Insulin Regional Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
  6.1. Russia
6.1.1. Russia Insulin Market, by Products
6.1.2. Russia Insulin Market, by Applications (only revenue)
6.1.3. Russia Insulin Market, by Source
  6.2. Poland
6.2.1. Poland Insulin Market, by Products
6.2.2. Poland Insulin Market, by Applications (only revenue)
6.2.3. Poland Insulin Market, by Source
  6.3. Turkey
6.3.1. Turkey Insulin Market, by Products
6.3.2. Turkey Insulin Market, by Applications (only revenue)
6.3.3. Turkey Insulin Market, by Source
  6.4. Ukraine
6.4.1. Ukraine Insulin Market, by Products
6.4.2. Ukraine Insulin Market, by Applications (only revenue)
6.4.3. Ukraine Insulin Market, by Source
  6.5. Uzbekistan
6.5.1. Uzbekistan Insulin Market, by Products
6.5.2. Uzbekistan Insulin Market, by Applications (only revenue)
6.5.3. Uzbekistan Insulin Market, by Source
  6.6. Belarus
6.6.1. Belarus Insulin Market, by Products
6.6.2. Belarus Insulin Market, by Applications (only revenue)
6.6.3. Belarus Insulin Market, by Source
  6.7. Kazakhstan
6.7.1. Kazakhstan Insulin Market, by Products
6.7.2. Kazakhstan Insulin Market, by Applications (only revenue)
6.7.3. Kazakhstan Insulin Market, by Source
  6.8. Rest of CIS
6.8.1. Rest of CIS Insulin Market, by Products
6.8.2. Rest of CIS Insulin Market, by Applications (only revenue)
6.8.3. Rest of CIS Insulin Market, by Source

Companies analysed in competitive landscape

1. Novo Nordisk
2. Sanofi
3. Eli Lilly
4. Bristol-Myers Squibb
5. Novartis
6. Takeda Pharmaceuticals
7. Boehringer Ingelheim
8. Biocon
9. Dongbao Enterprise Group Co., Ltd.
10. Merck KGaA
11. Oramed Pharmaceuticals Inc.
12. Halozyme Therapeutics
13. Wanbang Biopharma
14. Xinbai Pharmaceutical
15. Gan & Lee Pharmaceutical
16. Indrar
17. Farmak

List of Tables

1. CIS Insulin- Industry summary & Critical Success Factors (CSFs)
2. CIS Insulin Market, by Countries, 2012 - 2020 (USD Million)
3. CIS Insulin Market, by Products, 2012 - 2020 (USD Million)
4. CIS Insulin Market, by Products, 2012 - 2020 (‘000 Units)
5. CIS Insulin Market, by Applications, 2012 - 2020 (USD Million)
6. CIS Insulin Market, by Source Types, 2012 - 2020 (USD Million)
7. CIS Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
8. Russia Insulin Market, by Products, 2012 - 2020 (USD Million)
9. Russia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
10. Russia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
11. Russia Insulin Market, by Source Types, 2012 - 2020 (USD million)
12. Russia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
13. Russia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
14. Poland Insulin Market, by Products, 2012 - 2020 (USD Million)
15. Poland Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
16. Poland Insulin Market, by Product Types, 2012 - 2020 ('000 units)
17. Poland Insulin Market, by Source Types, 2012 - 2020 (USD million)
18. Poland Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
19. Poland Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
20. Turkey Insulin Market, by Products, 2012 - 2020 (USD Million)
21. Turkey Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
22. Turkey Insulin Market, by Product Types, 2012 - 2020 ('000 units)
23. Turkey Insulin Market, by Source Types, 2012 - 2020 (USD million)
24. Turkey Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
25. Turkey Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
26. Ukraine Insulin Market, by Products, 2012 - 2020 (USD Million)
27. Ukraine Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
28. Ukraine Insulin Market, by Product Types, 2012 - 2020 ('000 units)
29. Ukraine Insulin Market, by Source Types, 2012 - 2020 (USD million)
30. Ukraine Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
31. Ukraine Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
32. Uzbekistan Insulin Market, by Products, 2012 - 2020 (USD Million)
33. Uzbekistan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
34. Uzbekistan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
35. Uzbekistan Insulin Market, by Source Types, 2012 - 2020 (USD million)
36. Uzbekistan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
37. Uzbekistan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
38. Belarus Insulin Market, by Products, 2012 - 2020 (USD Million)
39. Belarus Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
40. Belarus Insulin Market, by Product Types, 2012 - 2020 ('000 units)
41. Belarus Insulin Market, by Source Types, 2012 - 2020 (USD million)
42. Belarus Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
43. Belarus Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
44. Kazakhstan Insulin Market, by Products, 2012 - 2020 (USD Million)
45. Kazakhstan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
46. Kazakhstan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
47. Kazakhstan Insulin Market, by Source Types, 2012 - 2020 (USD million)
48. Kazakhstan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
49. Kazakhstan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
50. Rest of CIS Insulin Market, by Products, 2012 - 2020 (USD Million)
51. Rest of CIS Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
52. Rest of CIS Insulin Market, by Product Types, 2012 - 2020 ('000 units)
53. Rest of CIS Insulin Market, by Source Types, 2012 - 2020 (USD million)
54. Rest of CIS Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
55. Rest of CIS Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)

List of Figures

1. CIS Insulin Market Segmentation
2. CIS Insulin Market Revenue, 2012 - 2020
3. CIS Insulin Market Dynamics
4. CIS Insulin Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. CIS Insulin PESTEL Analysis, 2012
8. CIS Insulin market - company market share analysis, 2013 (%)
9. CIS insulin market, by product type, 2012 - 2020
10. CIS insulin market, by source types, 2012 - 2020
11. CIS insulin market, by applications, 2012 - 2020

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.